UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of June, 2006
Commission File Number 000-28879
CHINA PHARMACEUTICALS INTERNATIONAL CORPORATION
(Translation of registrant’s name into English)
Room A, 22/F, Noble Center, 3rd Fu Zhong Road, Fu Tian District,
Shen Zhen, Guang Dong Province,
P.R. CHINA
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
| Yes o | No x |
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-__________
On June 30, 2006, YU Wai Kit resigned as Company Secretary of China Pharmaceuticals International Corporation.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CHINA PHARMACEUTICALS INTERNATIONAL CORPORATION
By: /s/ Fu Li
| Name: | Fu Li |
| ||
Date: July 27 2006 | Title: | Company Secretary | |||
2